Maxcyte (MXCT) Current Leases (2020 - 2026)

Maxcyte (MXCT) reported Current Leases of $1.4 million for Q1 2026, up 7.68% year-over-year from $1.3 million in Q1 2025, and down 5.63% on a QoQ basis from $1.5 million in Q4 2025.

Maxcyte (MXCT) has 7 years of Current Leases data on file, last reported at $1.4 million in Q1 2026.

  • Quarterly Current Leases rose 7.68% year-over-year to $1.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.4 million (up 7.68% YoY) and the FY2025 annual result came in at $1.5 million, up 68.52% from the prior year.
  • Current Leases fell to $1.4 million in Q1 2026 per MXCT's latest filing, from $1.5 million in the prior quarter.
  • Across five years, Current Leases topped out at $1.5 million in Q4 2025 and bottomed at $152200.0 in Q3 2022.
  • The 5-year median for Current Leases is $825000.0 (2024), against an average of $816270.6.
  • The widest annual swing landed in 2022, when Current Leases slumped 73.41%; it then jumped 392.99% in 2023.
  • Tracing MXCT's Current Leases over 5 years: stood at $157000.0 in 2022, then surged by 392.99% to $774000.0 in 2023, then climbed by 11.63% to $864000.0 in 2024, then jumped by 68.52% to $1.5 million in 2025, then retreated by 5.63% to $1.4 million in 2026.
  • Per Business Quant, the three latest MXCT Current Leases figures stand at $1.4 million (Q1 2026), $1.5 million (Q4 2025), and $1.3 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 24.30 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 20.50 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 35.80 Mn
10 Maxcyte 129.85 Mn 129.85 Mn 8.08 Mn 1.37 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 1.37 Mn
Dec 31, 2025 1.46 Mn
Sep 30, 2025 1.31 Mn
Jun 30, 2025 1.31 Mn
Mar 31, 2025 1.28 Mn
Dec 31, 2024 864,000.00
Sep 30, 2024 907,000.00
Jun 30, 2024 878,000.00
Mar 31, 2024 825,000.00
Dec 31, 2023 774,000.00
Sep 30, 2023 698,700.00
Jun 30, 2023 498,600.00
Mar 31, 2023 475,200.00
Dec 31, 2022 157,000.00
Sep 30, 2022 152,200.00
Jun 30, 2022 438,700.00
Mar 31, 2022 480,200.00
Dec 31, 2021 527,200.00
Sep 30, 2021 572,300.00
Jun 30, 2021 616,500.00
Dec 31, 2020 572,600.00